By | Been Written
Contributing Writer | Telegraph Local
During his “Fox & Friends” appearance, President Trump said a vaccine for coronavirus could be approved “in a matter of weeks.”
The fast-tracking for a vaccine, called “Operation Warp Speed”, involves several companies according to Trump.
The President added, “You wouldn’t have a vaccine for years … I speeded up the process with the FDA… We’re going to have a vaccine in a matter of weeks, it could be four weeks, it could be eight weeks … we have a lot of great companies.”
CNN reports that Kamala Harris said that President Donald Trump’s word alone on any potential coronavirus vaccine is not enough.
The Democratic Vice presidential nominee commented, “I will say that I would not trust Donald Trump and it would have to be a credible source of information that talks about the efficacy and the reliability of whatever he’s talking about,”
Harris did mention that she would trust the word of Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases.
Fauci has said he would get a Covid-19 vaccination once a vaccine proves to be safe and effective and becomes available.
Fauci told CNN’s Jim Sciutto, “I will look at the data and I would assume — and I’m pretty sure it’s going to be the case — that a vaccine would not be approved for the American public unless it was indeed both safe and effective,”
Due to rumors that the FDA and other health bodies are being “pressured” by the Trump administration to get a vaccine approved fast, Moncef Slaoui, the chief adviser to Operation Warp Speed, said in an interview with Science published Thursday that he would resign from his role if there was undue interference in the Covid-19 vaccine effort.
Trump’s press secretary Kayleigh McEnany said last Thursday that “No one is pressuring the FDA to do anything,”
The Food and Drug Administration is weighing whether to follow British regulators in resuming a coronavirus vaccine trial that was halted when a participant suffered spinal cord damage.
AstraZeneca, which is running the global trial of the vaccine it produced with Oxford University, said the trial volunteer recovered from a severe inflammation of the spinal cord and is no longer hospitalized.
Kaizer Family Foundation reports that ‘AstraZeneca has not confirmed that the patient was afflicted with transverse myelitis, but Nath and another neurologist said they understood this to be the case.’
The Mayo Clinic says that transverse myelitis is an inflammation of both sides of one section of the spinal cord. This neurological disorder often damages the insulating material covering nerve cell fibers (myelin).
Transverse myelitis interrupts the messages that the spinal cord nerves send throughout the body. This can cause pain, muscle weakness, paralysis, sensory problems, or bladder and bowel dysfunction.
Britain’s regulatory body, the Medicines and Healthcare Products Regulatory Agency, reviewed the case and has allowed the trial to resume in the United Kingdom.